Published in Biol Neonate on June 01, 2006
MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet (2007) 2.17
Patent ductus arteriosus: evidence for and against treatment. J Pediatr (2007) 2.10
Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med (2009) 1.41
Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed (2007) 1.34
Dynamic changes in the direction of blood flow through the ductus arteriosus at birth. J Physiol (2009) 1.22
Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. Development (2010) 1.10
Determination of genetic predisposition to patent ductus arteriosus in preterm infants. Pediatrics (2009) 0.99
Developmental and neuropathological consequences of ductal ligation in the preterm baboon. Pediatr Res (2009) 0.88
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Ital J Pediatr (2014) 0.86
B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants. Korean Circ J (2012) 0.86
Relationship between circulating platelet counts and ductus arteriosus patency after indomethacin treatment. J Pediatr (2010) 0.83
Ibuprofen treatment for closure of patent ductus arteriosus is not associated with increased risk of neuropathology. Pediatr Res (2010) 0.80
Improved closure of patent ductus arteriosus with high doses of ibuprofen. Pediatr Cardiol (2012) 0.79
Developmental changes in the effects of prostaglandin E2 in the chicken ductus arteriosus. J Comp Physiol B (2008) 0.79
Does primary surgical closure of the patent ductus arteriosus in infants <1500 g or ≤32 weeks' gestation reduce the incidence of necrotizing enterocolitis? Paediatr Child Health (2012) 0.78
Patent ductus arteriosus in premature neonates. Drugs (2012) 0.78
Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants. J Res Med Sci (2014) 0.78
Vessel remodeling in the newborn: platelets fill the gap. Nat Med (2010) 0.77
A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22-27 weeks gestational age. Crit Care Res Pract (2012) 0.77
Current Perspectives on Pathobiology of the Ductus Arteriosus. J Clin Exp Cardiolog (2012) 0.77
Does treatment of patent ductus arteriosus with cyclooxygenase inhibitors affect neonatal regional tissue oxygenation? Pediatr Cardiol (2012) 0.76
Thromboxane A(2) receptor stimulation promotes closure of the rat ductus arteriosus through enhancing neointima formation. PLoS One (2014) 0.76
Role of endothelin in uteroplacental circulation and fetal vascular function. Curr Vasc Pharmacol (2013) 0.75
Chorioamnionitis and Patent Ductus Arteriosus: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.75
Speckle-Tracking Echocardiography in Dogs With Patent Ductus Arteriosus: Effect of Percutaneous Closure on Cardiac Mechanics. J Vet Intern Med (2016) 0.75
Timing of surgical ligation and morbidities in very low birth weight infants. Medicine (Baltimore) (2017) 0.75
Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all? J Pediatr Pharmacol Ther (2009) 0.75
Outcomes of primary ligation of patent ductus arteriosus compared with secondary ligation after pharmacologic failure in very-low-birth-weight infants. Pediatr Cardiol (2013) 0.75
Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus. World J Clin Pediatr (2016) 0.75
Patent ductus arteriosus in preterm infant: Basic pathology and when to treat. Sudan J Paediatr (2014) 0.75
Doppler manifestations of ductal steal: role in decision making. Eur J Pediatr (2010) 0.75